BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Interferon alfa-2b (Intron A) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Interferon alfa-2b (Intron A)\, from Clin
 icalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03899987-9825@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Interferon alfa-2b (Intron A): Phase 2 readout est. (NCT03899987)
DESCRIPTION:Interferon alfa-2b (Intron A)\, phase 2.\nStudy: Aspirin and Ri
 ntatolimod With or Without Interferon-alpha 2b in Treating Patients With P
 rostate Cancer Before Surgery\nEstimated primary completion: 30 April 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/interferon-alfa-2b-
 intron-a#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT03899987
URL:https://assetmemo.bio/drug/interferon-alfa-2b-intron-a#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
